Every week I sit across from patients who have been told wildly different things about when to start injectables, what to get, and how much they need. Some come in at 24, convinced they need cheek filler. Others come in at 55, certain they’ve waited too long to do anything. Most of them are operating on advice from social media, a friend’s experience, or a provider who had one approach and applied it to everyone.
Here’s what I actually believe: there is no single answer, and anyone who gives you one without looking at your face first is guessing.
What I can offer is a framework. Aging happens in stages. The biology changes, the priorities shift, and the right tools change with them. Treating a 28-year-old like a 58-year-old is how faces start to look overdone. Treating a 58-year-old like a 28-year-old is how faces start to look distorted. A good injectable plan evolves over time, and understanding what’s actually happening in your face decade by decade makes it a lot easier to figure out what you actually need.
This is a roadmap, not a prescription. Real plans are individual. But here’s how I think about it.
Why Your Injectable Plan Should Change Every Decade
Facial aging isn’t one thing happening all at once. It’s a slow accumulation of changes across skin quality, soft tissue volume, fat pad position, muscle dynamics, and bone structure. In your 20s, the issue is primarily dynamic movement and sun damage starting to set in. By your 50s, you’re dealing with bone resorption, fat pad descent, and significant collagen loss all at the same time.
An injectable strategy that ignores this produces results that either look unnecessary or inadequate. The goal is to match the intervention to what’s actually going on, not to apply the same menu of treatments across every age group.
Injectables in Your 20s: Prevention, Not Correction
What’s actually happening to your face in your 20s
In your 20s, your collagen production is still robust, your fat pads are where they’re supposed to be, and your bone structure hasn’t changed. What you’re starting to see is the beginning of dynamic lines, the creases that appear when you move your face and, gradually, start to stick around when you don’t. Sun exposure, sleep habits, and repetitive facial expressions are laying the groundwork for what will become more visible in the next decade.
Baby Botox and microdosing: what makes sense and what doesn’t
Baby Botox, or microdosing with neuromodulators, is genuinely useful for some patients in their 20s. The concept is straightforward: instead of fully relaxing a muscle, you use smaller doses to soften movement without eliminating it. For someone who has a deep glabellar crease or pronounced crow’s feet already forming, strategic low-dose treatment can slow the progression of those lines becoming static.
What it is not is a universal starting point. I see a lot of 22-year-olds who don’t have a single line worth treating, and putting neuromodulators in their face at that stage isn’t prevention. It’s just treating something that doesn’t exist yet. The decision should be based on what you’re actually showing, not on an arbitrary age milestone.
Prejuvenation, when done correctly in this decade, means addressing early signs of dynamic line formation before they become entrenched. It doesn’t mean treating the entire face prophylactically.
Skin boosters and hydration injectables
This is where I think there’s genuine, underutilized value for patients in their 20s. Products like Skinvive and polynucleotide injectables work at the level of skin quality, improving hydration, smoothness, and overall texture without adding volume or freezing movement. For a patient in their 20s, this kind of treatment makes a lot of sense. You’re investing in the skin itself rather than trying to change your structural appearance.
Why most patients in their 20s don’t need filler yet
Volume loss is not a 20s problem for most people. Your fat pads are full, your cheeks have projection, your lips have natural volume. Adding filler to a face that doesn’t need structural support almost always looks like filler, not like a better version of your face.
There are exceptions. Some patients in their late 20s have naturally thin lips they’ve always wanted to address, or a specific feature they’ve always wanted to soften. That’s a different conversation than preventive filler, and it’s one worth having with a physician who will be honest with you about what’s realistic.
What to skip in your 20s
Cheek filler for prevention. Jawline contouring for trend purposes. Significant lip overfilling. These treatments in a 20-year-old face almost universally produce the “done” look that ages poorly, distorts natural proportions, and creates problems that are harder to correct than the original concern.
Injectables in Your 30s: Maintenance and Early Structural Support
What’s changing
Starting in your mid-20s and accelerating through your 30s, collagen production drops roughly 1% per year. The dynamic lines you were softening with baby Botox start to leave impressions even at rest. Some patients begin to notice the first subtle signs of volume change, particularly in the lips and under the eyes, and early shadowing in the mid-face.
Standard-dose neuromodulators for dynamic lines
This is the decade where standard Botox dosing starts to make more sense. Forehead lines, the glabellar complex (the 11s between your brows), and crow’s feet are the primary targets. The goal is still softening movement and preventing lines from deepening, but with more established lines, you often need more than a microdose to accomplish that.
When filler starts to make sense
For patients in their 30s, small amounts of filler in specific areas can start to make sense. Lip augmentation for patients who’ve noticed natural volume loss, tear trough treatment for patients with significant under-eye hollowing, and very conservative mid-face support in patients who are showing early volume depletion are all legitimate considerations. The key word is small. This is not the decade for significant structural overhaul. It’s the decade for maintaining and subtly supporting what you have.
The role of biostimulators
Sculptra, which works by stimulating your own collagen production rather than filling a space, is something I start introducing as a conversation in the 30s for patients who want to be proactive about long-term collagen support. It’s not always necessary, but for patients who want to invest in prevention rather than wait for correction, it’s worth discussing.
Combination strategy
Injectables alone don’t maintain results or slow aging the way they do when paired with a solid skincare regimen and consistent sun protection. If you’re treating dynamic lines with neuromodulators and ignoring SPF, you’re working against yourself.
Injectables in Your 40s: Structure, Balance, and Skin Quality
What’s changing
The 40s bring structural changes that weren’t a factor in previous decades. Bone resorption starts to reduce the scaffolding that holds soft tissue in place. Fat pads begin to descend. Skin laxity increases, and the combination creates the appearance of volume loss even in people who haven’t lost actual fat. The face starts to look tired before it looks old, and that distinction matters for treatment.
Strategic filler for support, not volume
The approach to filler shifts significantly in your 40s. You’re not adding volume for cosmetic reasons. You’re restoring structural support where bone and soft tissue changes have created deficits. Cheek and temple filler, placed correctly, lift and support the mid-face in a way that looks natural because it’s addressing the actual anatomical change. Jawline treatment can sharpen a contour that’s been softened by fat pad descent.
The risk in this decade is overdoing it. More filler does not mean more youthful. It means more filler. Strategic, precise placement with appropriate volumes is what produces a result that looks like you at your best.
Biostimulators as a foundation
Sculptra and Radiesse both earn a more prominent role in your 40s. Because the underlying issue is collagen loss and structural change, treatments that stimulate your own tissue to rebuild are often more appropriate than simply filling spaces. I use biostimulators to rebuild the foundation and reserve hyaluronic acid fillers for targeted refinement.
Shifting neuromodulator strategy
Some patients in their 40s find that their neuromodulator dosing needs to be reassessed. Muscle dynamics change, and patterns that worked in your 30s may not produce the same results. It’s also worth considering how relaxing certain muscles affects the overall appearance. In a younger face, a frozen forehead mostly just looks frozen. In a 40-something face with other changes happening, it can affect how the brow sits and how the upper face relates to the rest.
Skin quality alongside injectables
If you’re not incorporating energy-based treatments or medical-grade skincare in your 40s, you’re leaving real results on the table. Lasers and microneedling address skin quality in ways that injectables can’t, and they work synergistically with what you’re doing with filler and neuromodulators.
Injectables in Your 50s: Rebuilding, Restoring, and Aging Well
What’s changing
Post-menopausal collagen loss is accelerated and significant. Estrogen plays a direct role in collagen synthesis, and its decline in the 50s produces a measurable drop in skin thickness, elasticity, and hydration. Volume loss becomes more pronounced, facial ligaments loosen, and the structural changes from the previous decade compound.
Biostimulators as the foundation
In your 50s, I think about biostimulators not as an add-on but as the central strategy. Rebuilding collagen from within, consistently and over time, addresses the underlying biology in a way that surface treatments don’t. Sculptra requires patience because results develop gradually, but the quality of those results and their durability make it the right foundation for most patients in this decade.
Strategic filler: where it helps and where it doesn’t
Hyaluronic acid fillers remain useful in the 50s for specific targeted areas, but the risk of looking overdone increases when filler is used broadly to compensate for what is fundamentally a structural and skin quality issue. Volume for volume’s sake in this decade tends to produce heaviness rather than youthfulness. The right question is always: where does the anatomy actually need support?
Neuromodulators for static lines
By your 50s, many lines that were once dynamic are now static, meaning they’re present even without muscle movement. Neuromodulators still help by preventing deepening, but they won’t erase lines that have become etched into the skin. Managing patient expectations honestly at this stage matters as much as the treatment itself.
Energy-based devices
Skin tightening and resurfacing treatments become increasingly relevant in the 50s. Injectable results are only as good as the skin quality they’re working within, and addressing laxity and texture with appropriate energy-based devices dramatically improves the overall outcome.
Injectables in Your 60s and Beyond: Refinement and Restoration
What’s changing
By the 60s, structural and skin quality concerns have fully merged. Bone resorption is significant, facial ligaments are lax, skin is thinner and less elastic, and the face has lost substantial soft tissue volume. The range of what injectables can accomplish narrows, and an honest conversation about realistic expectations becomes more important than ever.
Why less volume often looks better at this stage
The instinct to restore volume to a 60-something face is understandable, but overvolumizing at this stage is one of the most common ways injectables go wrong. A face that has undergone significant structural change does not simply return to a younger version of itself when you add filler back in. The distribution of that volume matters enormously, and adding too much produces a puffy, distorted result rather than a rejuvenated one. Precision matters more here than at any other decade.
Biostimulators for ongoing collagen support
Continuing biostimulator treatments in your 60s supports skin quality and tissue integrity in a way that complements whatever structural work you’re doing. It’s a maintenance strategy more than a transformation strategy, but that’s appropriate for this stage.
When injectables are enough and when surgery is a better answer
This is a conversation I have regularly with patients in their 60s and I think it’s an important one. Injectables are extraordinary tools, but they have limits. Significant skin laxity, pronounced jowling, and advanced ptosis are structural issues that injectables can improve but not fully correct. If those are your primary concerns and you want a meaningful change, a surgical consultation is worth having. That’s not a failure of injectables. It’s an honest assessment of what each tool is actually designed to do.
What Stays Consistent at Every Age
A few principles don’t change regardless of what decade you’re in.
Sun protection is the single biggest factor in how your skin ages and how long your injectable results last. I tell every patient this. SPF is not optional.
A board-certified physician who knows facial anatomy is not interchangeable with a nurse at a discount med spa. The face is too complex and the margin for error too narrow. Who does your injectables matters more than what you pay.
A full-face assessment always produces better results than spot-treating. One area of the face affects every other area. Good injection planning takes the whole picture into account.
And at every age, the ability to say no to overdone trends is what separates results that age well from results that become problems. Just because something is popular on social media doesn’t mean it belongs on your face.
What I Tell Patients About Timing Their First (or Next) Injectable
There is no universal right age to start. There is no expiration date on beginning treatment. Prevention is easier than correction, which is why I support early, targeted intervention when it’s appropriate. But correction is always possible, and the patients who come to me in their 50s and 60s having never done anything still have real options.
What I look for in every new patient is what’s actually happening in their face right now, what they want to look like, and what tools make the most sense at their current stage. That’s the only framework that produces results that look like you, only better.
If you’ve been wondering whether it’s the right time to start, or whether what you’ve been doing still makes sense for where you are, that conversation starts with a consultation. Book yours at Line Eraser MD and we’ll figure out what your roadmap actually looks like.
